• AK Medical offered 355,000 share options on July 23, 2026, exercisable at HK$ 5.84 from July 23, 2026 to July 22, 2036.
• Half vest on July 23, 2027; remainder on July 23, 2028, subject to company financial metrics and individual performance assessments.
• Executive director Zhao Xiaohong received 103,000 options.
• Separately offered 1,260,000 awarded shares valued at HK$ 7.07 million, based on a HK$ 5.61 closing price.
• Awarded shares vest 50% in 2027, 50% in 2028; Zhao Xiaohong received 79,000 awarded shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260723-12254595), on July 23, 2026, and is solely responsible for the information contained therein.